| Screening and prostate-cancer mortality in a randomized European study FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ... New England journal of medicine 360 (13), 1320-1328, 2009 | 5433 | 2009 |
| EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ... European urology 71 (4), 618-629, 2017 | 3776 | 2017 |
| EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013 A Heidenreich, PJ Bastian, J Bellmunt, M Bolla, S Joniau, T van der Kwast, ... European urology 65 (1), 124-137, 2014 | 2483 | 2014 |
| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 243-262, 2021 | 2468 | 2021 |
| EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease A Heidenreich, J Bellmunt, M Bolla, S Joniau, M Mason, V Matveev, ... European urology 59 (1), 61-71, 2011 | 1984 | 2011 |
| Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ... The Lancet 384 (9959), 2027-2035, 2014 | 1959 | 2014 |
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer A Heidenreich, PJ Bastian, J Bellmunt, M Bolla, S Joniau, T van der Kwast, ... European urology 65 (2), 467-479, 2014 | 1926 | 2014 |
| Prostate-cancer mortality at 11 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ... New England Journal of Medicine 366 (11), 981-990, 2012 | 1803 | 2012 |
| EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis, T Gross, AM Henry, ... European urology 71 (4), 630-642, 2017 | 1621 | 2017 |
| External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study M Bolla, G Van Tienhoven, P Warde, JB Dubois, RO Mirimanoff, G Storme, ... The lancet oncology 11 (11), 1066-1073, 2010 | 1101 | 2010 |
| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 263-282, 2021 | 917 | 2021 |
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer N Mottet, J Bellmunt, M Bolla, S Joniau, M Mason, V Matveev, HP Schmid, ... Actas Urológicas Españolas (English Edition) 35 (10), 565-579, 2011 | 745 | 2011 |
| Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer MA Haider, TH Van Der Kwast, J Tanguay, AJ Evans, AT Hashmi, ... American journal of roentgenology 189 (2), 323-328, 2007 | 733 | 2007 |
| Urine markers for bladder cancer surveillance: a systematic review BWG Van Rhijn, HG Van der Poel, TH van Der Kwast European urology 47 (6), 736-748, 2005 | 704 | 2005 |
| Guidelines on A Heidenreich, M Bolla, S Joniau, MD Mason, V Matveev, N Mottet, ... Update, 2007 | 686 | 2007 |
| Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization G Jenster, HAGM van der Korput, C van Vroonhoven, TH van der Kwast, ... Molecular endocrinology 5 (10), 1396-1404, 1991 | 673 | 1991 |
| A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer J Hugosson, MJ Roobol, M Månsson, TLJ Tammela, M Zappa, V Nelen, ... European urology 76 (1), 43-51, 2019 | 629 | 2019 |
| Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017 | 628 | 2017 |
| Guidelines on prostate cancer N Mottet, J Bellmunt, E Briers, RCN Van den Bergh, M Bolla, ... European Association of Urology 56, e137, 2015 | 616 | 2015 |
| Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors C Billerey, D Chopin, MH Aubriot-Lorton, D Ricol, SGD de Medina, ... The American journal of pathology 158 (6), 1955-1959, 2001 | 616 | 2001 |